Cleared Traditional

QSCHECK UISACR

K252619 · Qstag, Inc. · Chemistry
Feb 2026
Decision
185d
Days
Class 2
Risk

About This 510(k) Submission

K252619 is an FDA 510(k) clearance for the QSCHECK UISACR, a Enzymatic Method, Creatinine (Class II — Special Controls, product code JFY), submitted by Qstag, Inc. (Incheon, KR). The FDA issued a Cleared decision on February 20, 2026, 185 days after receiving the submission on August 19, 2025. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1225.

Submission Details

510(k) Number K252619 FDA.gov
FDA Decision Cleared SESE
Date Received August 19, 2025
Decision Date February 20, 2026
Days to Decision 185 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code JFY — Enzymatic Method, Creatinine
Device Class Class II — Special Controls
CFR Regulation 21 CFR 862.1225

Similar Devices — JFY Enzymatic Method, Creatinine

All 48
Atellica CH Enzymatic Creatinine_3 (ECre3)
K212223 · Siemens Healthcare Diagnostics, Inc. · Nov 2021
Yumizen C1200 Creatinine PAP
K193649 · HORIBA ABX SAS · May 2021
ACR LAB Urine Analysis Test System
K182384 · Healthy.Io, Ltd. · Jul 2019
GEM Premier ChemSTAT
K183555 · Instrumentation Laboratory CO · Feb 2019
URiSCAN 10ACR urine strips on the URiSCAN Optima urine analyzer
K182038 · Yd Diagnostics Corporation · Dec 2018
VITROS Chemistry Products CRBM Slides, VITROS Chemistry Products CREA Slides, VITROS Chemistry Products TBIL Slides, VITROS XT 7600 Integrated System
K182063 · Ortho-Clinical Diagnostics, Inc. · Oct 2018